Public Health is for Everyone An inclusive planning toolkit for public health professionals

Plain language factsheets with easy to read information about COVID-19 and the vaccine.

Use this resources to find maps and charts tracking cases, deaths, and trends of COVID-19 in the United States, updated daily by 8 pm ET.

Learn more about the COVID Data Tracker, CDC's home for COVID-19 data, including vaccinations, cases, and hospitalizations and more. It offers easy-to-interpret visualizations, such as interactive maps and graphs. Visit COVID Data Tracker for more information. 

This toolkit provides resources and tools to help pregnant people, breastfeeding people, and new parents caring for infants to protect their health and help people who serve these communities communicate with them.

This dashboard was created as a partnership between the Johns Hopkins Disability Health Research Center and the Center for Dignity in Healthcare for People with Disabilities as a starting point for understanding how the disability community is prioritized in COVID-19 vaccine distribution and intends to help people with disabilities determine when they qualify for a COVID-19 vaccine in their state.

This tool tracks vaccine prioritization plans across four categories for the 50 US states, 5 US territories, and the District of Columbia:

1. Long-term care settings, such as nursing homes
2. Other types of congregate care settings, including group homes
3. People with chronic conditions
4. Additional disability-related groups, including three main groups: (1) people with disabilities who receive direct support care in the community, (2) people with intellectual or developmental disabilities, or (3) recipients of certain Medicaid programs

View this resource for frequently asked questions about the COVID-19 vaccine.

Ensuring strong demand for the COVID-19 vaccines is critical to achieving herd immunity, protecting the most vulnerable populations, and reopening social and economic life. But about 31% of US adults are hesitant to get a vaccine.1 Public engagement and clear and transparent messaging play a central role in building COVID-19 vaccine confidence.It will take a variety of strategies at the national, state, and local levels to engage with the public, address vaccine hesitancy, and build trust. At the local level, listening to community members to identify and understand concerns will help determine what messaging, delivered by whom, will be most effective.

The public's opinions on vaccination fall along a continuum, ranging from those who fully accept vaccines, to those who are vaccine hesitant, to those strongly or unequivocally opposed to vaccination (a very small minority of the population).2 The vaccine hesitant group is most likely to respond to efforts to build vaccine confidence. For these individuals, resources, information, and support are needed. This rapid expert consultation highlights strategies for engaging with the public and communicating effectively to ensure demand and promote acceptance. These strategies are informed by five principles for effective risk communication.

During a time when in-person interactions pose health risks due to possible exposure of the virus, lack
of access to broadband Internet can have far reaching consequences for older adults, such as
challenges enrolling in benefit programs that provide much needed financial assistance for needslike
food, health care, and energy assistance; challenges accessing services and being connected to service
and health care providers; and challenges with social isolation, including prevention of connection with
friends, family, and various support networks. Health and safety guidelines themselves can have the
paradoxical effect of increasing social isolation, particularly for older adults. Measures such as physical
distancing, stay-at-home or safe-at-home guidance, and limitations on interactions, services, or
gatherings in physical settings, while important for limiting disease transmission, can result in greater
isolation from others. State aging and disabilities agencies were asked if individuals that their agency serve have been impacted by a lack of access to broadband Internet.

Informational videos about COVID-19 in American Sign Language.

A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions. The COVID-19 Neuro Databank/Biobank (NeuroCOVID), which was created and will be maintained by NYU Langone Health, New York City, will be a resource of clinical information as well as biospecimens from people of all ages who have experienced neurological problems associated with SARS-CoV-2 infection. The database is supported by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS).